Characterisation of the differential response of normal and CML haemopoietic progenitor cells to macrophage inflammatory protein-1α

Open Access
Publisher Website
Google Scholar
Abstract
The clonogenic cells of chronic myeloid leukaemia (CML), unlike normal haemopoietic colony forming cells (CFC), are resistant to the growth inhibitory effects of the chemokine, macrophage inflammatory protein-1α (MIP-1α). Here, we tested the hypothesis that MIP-1α protects normal, but not CML, CFC from the cytotoxic effects of the cell-cycle active drug cytosine arabinoside (Ara-C). Using a 24-h Ara-C protection assay we showed that MIP-1α confers protection to normal CFC but also sensitises CML CFC to Ara-C. The differential MIP-1α responsiveness was not due to a down-regulation of MIP-1α receptors on CML CD34+ cells as flow cytometric analysis showed similar binding of a biotinylated MIP-1α molecule to normal and CML CD34+ cells. Flow cytometric analysis of the MIP-1α receptor subtype CCR-5 revealed comparable CCR-5 expression levels on normal and CML CD34+ cells. Furthermore, culture of CD34+ cells for 10 h in the presence of TNF-α resulted in an increased MIP-1α receptor expression on both normal and CML CD34+ cells. Our data suggest that the unresponsiveness of CML CFC to the growth inhibitory effect of MIP-1α is not caused by a lack of MIP-1α receptor or total uncoupling of the MIP-1α responsiveness but may be due to an intracellular signalling defect downstream of the receptors.

This publication has 0 references indexed in Scilit: